MHR
RMD icon

Matthew Hamilton Rosenberg’s ResMed RMD Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-176
Closed -$39.5K – 813
2026
Q1 		$39.5K Hold
176
– – 0.01% 457
2025
Q4 		$42.4K Hold
176
– – 0.01% 450
2025
Q3 		$48.2K Hold
176
– – 0.01% 429
2025
Q2 		$45.4K Sell
176
-62
-26% -$14.8K 0.01% 453
2025
Q1 		$53.3K Hold
238
– – 0.01% 417
2024
Q4 		$54.4K Buy
+238
New +$57.3K 0.01% 410

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Matthew Hamilton Rosenberg's RMD Position: Q2 2026 in Review

Matthew Hamilton Rosenberg sold out of ResMed (RMD) in Q2 2026, closing a stake of 176 shares — an estimated $39.5K sold.

Matthew Hamilton Rosenberg first reported a position in RMD in Q4 2024 and held it in 6 quarters. The position peaked at $54.4K in Q4 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Matthew Hamilton Rosenberg reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 176 ResMed shares in Q2 2026, an estimated $39.5K.
  • Matthew Hamilton Rosenberg first reported a position in ResMed in Q4 2024 and held it in 6 quarters.
  • Matthew Hamilton Rosenberg's ResMed position peaked at $54.4K in Q4 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.